TherapeuticsMD Inc
TherapeuticsMD Inc logo
TXMD

TherapeuticsMD Inc (TXMD)

$100.35%

  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$9.95
Day's Range
$10.0
$1.99
52-Week Range
$57.87
1 month return0.05%
3 month return42.84%
1 year return82.36%
5 year return96.47%

Company Information

TherapeuticsMD Inc. is an inventive pharmaceutical company that focuses exclusively on healthcare products for women and informs on women’s health problems. The company is dedicated to producing advanced therapeutic products related to family planning, reproductive health, and menopause management with the view to addressing the unique challenges that women face in the different phases of their lives. Founded in 2008 by Brian Bernick and Robert Finizio, the company is headquartered in Boca Raton, Florida. TherapeuticsMD delivers bio-identical hormones in various forms and administration methods using its homegrown SYMBODA technology. It makes fetal vitamins and other nutritional supplements under its vitaMedMD brand and exclusively prescribed prenatal vitamins through BocaGreenMD. These products are produced by a third-party manufacturer- Lang Pharma Nutrition. The company's solutions include long-lasting contraceptives, pharmaceutical products for hormone therapy, and patient-controlled contraceptives. Aside from developing prescription-only hormone therapy products for women, TherapeuticsMD is designing products to address menopausal vasomotor symptoms and dyspareunia. Currently, the firm markets and sells its products through a direct national sales force of about 50 full-time professionals that target health care providers in the OB/GYN sector. Medical professionals may also be able to provide patients with an alternative that meets their individual nutritional and financial needs about co-pays and costs of care and saves them money compared with competing products.. Currently TherapeuticsMD Inc has a market cap of $0.09 Billion. It has a P.E ratio of -0.46. The shares of TherapeuticsMD Inc are trading at $9.97. .
OrganizationTherapeuticsMD Inc
Employees3000
CEORobert Finizio
IndustryHealth Technology

Analyst Recommendation

based on 9 analysts ratings

Buy
88%
Buy
11%
Hold
0%
Sell

Based on 9 Wall street analysts offering stock ratings for TherapeuticsMD Inc(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Downside of 59.88%

Current

$9.97

Target

$4.0

Recommendation Trend

Based on 9 analyst

Current1M Ago3M Ago
Buy
8
8
9
Hold
1
1
1
Sell
0
0
0
Consensus
BUY
BUY
BUY

Company Financials

  • Annual
  • Quarterly

Highlights

Market Capitalization
93.6M
Book Value
0.03
Dividend Share
0.0
Dividend Yield
0.0
Earnings Share
-0.43
PEG Ratio
-0.73
Wall Street Target Price
4.17

Valuation

Trailing PE0.0
Forward PE0.0
Price/Sales (ttm)
1.08
Price/Book (mrq)
40.75
Enterprise Value
229.1M
Enterprise Value/Revenue
2.63
Enterprise Value/Ebitda
0.0

Technicals

Beta
1.9
50 Day MA
0.3
200 Day MA
0.55

Institutional Holdings

BlackRock Inc

5.65%

Vanguard Group Inc

3.96%

Morgan Stanley - Brokerage Accounts

1.76%

State Street Corporation

1.65%

Geode Capital Management, LLC

1.5%

CAM Group Holding A/S

1.41%

Discover more

Frequently Asked Questions

What is TherapeuticsMD Inc share price today?

Can Indians buy TherapeuticsMD Inc shares?

How can I buy TherapeuticsMD Inc shares from India?

Can Fractional shares of TherapeuticsMD Inc be purchased?

What are the documents required to start investing in TherapeuticsMD Inc stocks?

What are today’s High and Low prices of TherapeuticsMD Inc?

What are today’s traded volumes of TherapeuticsMD Inc?

What is today’s market capitalisation of TherapeuticsMD Inc?

What is the 52 Week High and Low Range of TherapeuticsMD Inc?

How much percentage TherapeuticsMD Inc is down from its 52 Week High?

How much percentage TherapeuticsMD Inc is up from its 52 Week low?

What are the historical returns of TherapeuticsMD Inc?

Who is the Chief Executive Officer (CEO) of TherapeuticsMD Inc?